While fondaparinux has been available for nearly a decade, its use has not been nearly as extensive as the use of LMWHs. Thus, clinical experience with this agent and outcomes data are far more ...

Main Objectives. This was a randomized, double-blind trial of fondaparinux in patients with STEMI. The primary objective of the study was to evaluate the impact of fondaparinux as an anticoagulant ...

Recent data have shown that fondaparinux, a selective factor Xa inhibitor, is noninferior to enoxaparin for short-term prevention of adverse cardiovascular outcomes in patients with non-ST-segment ...

Blood clots can be lifesaving when they stop bleeding caused by a cut or injury. But they can be deadly if they form when and where they aren't needed. That's why the news in late December 2012 ...

Myocardial Infarction, Cardiovascular Disease, Prevention, Challenges, Review Abdin, A. (2024) Myocardial Infarction and the Prevention Strategies Keeping it at Bay: A Narrative Review. Open Access ...

Dieser Artikel basiert auf dem Artikel Fondaparinux aus der freien Enzyklopädie Wikipedia und steht unter der GNU-Lizenz für freie Dokumentation. In der Wikipedia ist eine Liste der Autoren verfügbar.

Check out the full article here Anticoagulants: Drugs that prevent further clot formation. Heparin. Warfarin. Fondaparinux ...